Clinical trial / 2013
Soy protein isolate did not lower prostate cancer recurrence after radical prostatectomy.
A multicenter trial randomized 177 men at high risk of prostate cancer recurrence to receive daily powder with 20 g of soy protein isolate or calcium caseinate for up to 2 years. The trial was halted early for futility after an interim analysis of 159 evaluable men. Biochemical recurrence developed in 27.2% of the soy group and 29.5% of the placebo group, showing no significant difference (hazard ratio 0.96; 95% CI, 0.53-1.72; P = .89).
- Study type
- Randomized controlled trial
- Who was studied
- 177 men at high risk of prostate cancer recurrence, United States
- What was measured
- Biochemical recurrence rate of prostate cancer
THE PAPER
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, Xie H, Gao W, Walden P, Lepor H, Taneja SS, Randolph C, Schlicht MJ, Meserve-Watanabe H, Deaton RJ, Davies JA. JAMA, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.